Industry: Medical Devices & Consumables
Published Date: 2026-01-08
Pages: 96 Pages
Report ld: 5594197
Request Sample
Customized Report
Drainage Endobronchial Blocker Market Size(US$)

CAGR 2026-2032
3.3%
Market Size,2032
USD 372
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Drainage Endobronchial Blocker was estimated to be worth US$ 299 million in 2025 and is projected to reach US$ 372 million, growing at a CAGR of 3.3% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Drainage Endobronchial Blocker cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
A drainage-type endobronchial blocker is a specially designed medical device that can be inserted into the bronchus to block the ventilation of a specific lobe or segment of the lung and has a drainage function. This device is usually inserted through a bronchoscope or fiber bronchoscope to ensure accurate placement. A drainage-type endobronchial blocker usually consists of a catheter for guiding the blocker into the bronchus, an inflatable balloon part for tightly fitting the bronchial wall to achieve the blocking function, an inflation connector for connecting an inflation device to inflate or deflate the balloon, and a drainage channel designed to drain liquid or gas in the bronchus.
The North American market for Drainage Endobronchial Blocker was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Drainage Endobronchial Blocker was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Drainage Endobronchial Blocker was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Drainage Endobronchial Blocker market include 3M, Solvay, DuPont, BASF, Chemours, AGC Chemicals, Nantong Xingchen Synthetic Materials, Xinguang Chemical, Wanhua Chemical, Dongyue Group, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Drainage Endobronchial Blocker, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Drainage Endobronchial Blocker market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Drainage Endobronchial Blocker.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Drainage Endobronchial Blocker manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Drainage Endobronchial Blocker sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Drainage Endobronchial Blocker sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Drainage Endobronchial Blocker Product Introduction
1.2 Global Drainage Endobronchial Blocker Market Size Forecast
1.2.1 Global Drainage Endobronchial Blocker Sales Value (2021–2032)
1.2.2 Global Drainage Endobronchial Blocker Sales Volume (2021–2032)
1.2.3 Global Drainage Endobronchial Blocker Sales Price (2021–2032)
1.3 Drainage Endobronchial Blocker Market Trends & Drivers
1.3.1 Drainage Endobronchial Blocker Industry Trends
1.3.2 Drainage Endobronchial Blocker Market Drivers & Opportunities
1.3.3 Drainage Endobronchial Blocker Market Challenges
1.3.4 Drainage Endobronchial Blocker Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drainage Endobronchial Blocker Players Revenue Ranking (2025)
2.2 Global Drainage Endobronchial Blocker Revenue by Company (2021–2026)
2.3 Global Drainage Endobronchial Blocker Sales Volume Ranking of Players (2025)
2.4 Global Drainage Endobronchial Blocker Sales Volume by Company (2021–2026)
2.5 Global Drainage Endobronchial Blocker Average Price by Company (2021–2026)
2.6 Key Manufacturers Drainage Endobronchial Blocker Manufacturing Base and Headquarters
2.7 Key Manufacturers Drainage Endobronchial Blocker Product Offerings
2.8 Key Manufacturers Start of Mass Production of Drainage Endobronchial Blocker
2.9 Drainage Endobronchial Blocker Market Competitive Analysis
2.9.1 Drainage Endobronchial Blocker Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Drainage Endobronchial Blocker Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drainage Endobronchial Blocker revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Drainage Endobronchial Blocker Market Classification
3.1 Introduction by Type
3.1.1 Unilateral Blocking
3.1.2 Bilateral Blocking
3.1.3 Global Drainage Endobronchial Blocker Sales Value by Type
3.1.3.1 Global Drainage Endobronchial Blocker Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Drainage Endobronchial Blocker Sales Value, by Type (2021–2032)
3.1.3.3 Global Drainage Endobronchial Blocker Sales Value, by Type (%), 2021–2032
3.1.4 Global Drainage Endobronchial Blocker Sales Volume by Type
3.1.4.1 Global Drainage Endobronchial Blocker Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Drainage Endobronchial Blocker Sales Volume, by Type (2021–2032)
3.1.4.3 Global Drainage Endobronchial Blocker Sales Volume, by Type (%), 2021–2032
3.1.5 Global Drainage Endobronchial Blocker Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Treatment of Respiratory Diseases
4.1.2 Chest Surgery
4.1.3 Other
4.2 Global Drainage Endobronchial Blocker Sales Value by Application
4.2.1 Global Drainage Endobronchial Blocker Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Drainage Endobronchial Blocker Sales Value, by Application (2021–2032)
4.2.3 Global Drainage Endobronchial Blocker Sales Value, by Application (%), 2021–2032
4.3 Global Drainage Endobronchial Blocker Sales Volume by Application
4.3.1 Global Drainage Endobronchial Blocker Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Drainage Endobronchial Blocker Sales Volume, by Application (2021–2032)
4.3.3 Global Drainage Endobronchial Blocker Sales Volume, by Application (%), 2021–2032
4.4 Global Drainage Endobronchial Blocker Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Drainage Endobronchial Blocker Sales Value by Region
5.1.1 Global Drainage Endobronchial Blocker Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Drainage Endobronchial Blocker Sales Value by Region (2021–2026)
5.1.3 Global Drainage Endobronchial Blocker Sales Value by Region (2027–2032)
5.1.4 Global Drainage Endobronchial Blocker Sales Value by Region (%), 2021–2032
5.2 Global Drainage Endobronchial Blocker Sales Volume by Region
5.2.1 Global Drainage Endobronchial Blocker Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Drainage Endobronchial Blocker Sales Volume by Region (2021–2026)
5.2.3 Global Drainage Endobronchial Blocker Sales Volume by Region (2027–2032)
5.2.4 Global Drainage Endobronchial Blocker Sales Volume by Region (%), 2021–2032
5.3 Global Drainage Endobronchial Blocker Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Drainage Endobronchial Blocker Sales Value, 2021–2032
5.4.2 North America Drainage Endobronchial Blocker Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Drainage Endobronchial Blocker Sales Value, 2021–2032
5.5.2 Europe Drainage Endobronchial Blocker Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Drainage Endobronchial Blocker Sales Value, 2021–2032
5.6.2 Asia Pacific Drainage Endobronchial Blocker Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Drainage Endobronchial Blocker Sales Value, 2021–2032
5.7.2 South America Drainage Endobronchial Blocker Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Drainage Endobronchial Blocker Sales Value, 2021–2032
5.8.2 Middle East & Africa Drainage Endobronchial Blocker Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drainage Endobronchial Blocker Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Drainage Endobronchial Blocker Sales Value and Sales Volume
6.2.1 Key Countries/Regions Drainage Endobronchial Blocker Sales Value, 2021–2032
6.2.2 Key Countries/Regions Drainage Endobronchial Blocker Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Drainage Endobronchial Blocker Sales Value, 2021–2032
6.3.2 United States Drainage Endobronchial Blocker Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Drainage Endobronchial Blocker Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Drainage Endobronchial Blocker Sales Value, 2021–2032
6.4.2 Europe Drainage Endobronchial Blocker Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Drainage Endobronchial Blocker Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Drainage Endobronchial Blocker Sales Value, 2021–2032
6.5.2 China Drainage Endobronchial Blocker Sales Value by Type (%), 2025 vs 2032
6.5.3 China Drainage Endobronchial Blocker Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Drainage Endobronchial Blocker Sales Value, 2021–2032
6.6.2 Japan Drainage Endobronchial Blocker Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Drainage Endobronchial Blocker Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Drainage Endobronchial Blocker Sales Value, 2021–2032
6.7.2 South Korea Drainage Endobronchial Blocker Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Drainage Endobronchial Blocker Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Drainage Endobronchial Blocker Sales Value, 2021–2032
6.8.2 Southeast Asia Drainage Endobronchial Blocker Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Drainage Endobronchial Blocker Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Drainage Endobronchial Blocker Sales Value, 2021–2032
6.9.2 India Drainage Endobronchial Blocker Sales Value by Type (%), 2025 vs 2032
6.9.3 India Drainage Endobronchial Blocker Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 3M
7.1.1 3M Company Information
7.1.2 3M Introduction and Business Overview
7.1.3 3M Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 3M Drainage Endobronchial Blocker Product Offerings
7.1.5 3M Recent Developments
7.2 Solvay
7.2.1 Solvay Company Information
7.2.2 Solvay Introduction and Business Overview
7.2.3 Solvay Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Solvay Drainage Endobronchial Blocker Product Offerings
7.2.5 Solvay Recent Developments
7.3 DuPont
7.3.1 DuPont Company Information
7.3.2 DuPont Introduction and Business Overview
7.3.3 DuPont Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 DuPont Drainage Endobronchial Blocker Product Offerings
7.3.5 DuPont Recent Developments
7.4 BASF
7.4.1 BASF Company Information
7.4.2 BASF Introduction and Business Overview
7.4.3 BASF Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 BASF Drainage Endobronchial Blocker Product Offerings
7.4.5 BASF Recent Developments
7.5 Chemours
7.5.1 Chemours Company Information
7.5.2 Chemours Introduction and Business Overview
7.5.3 Chemours Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Chemours Drainage Endobronchial Blocker Product Offerings
7.5.5 Chemours Recent Developments
7.6 AGC Chemicals
7.6.1 AGC Chemicals Company Information
7.6.2 AGC Chemicals Introduction and Business Overview
7.6.3 AGC Chemicals Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 AGC Chemicals Drainage Endobronchial Blocker Product Offerings
7.6.5 AGC Chemicals Recent Developments
7.7 Nantong Xingchen Synthetic Materials
7.7.1 Nantong Xingchen Synthetic Materials Company Information
7.7.2 Nantong Xingchen Synthetic Materials Introduction and Business Overview
7.7.3 Nantong Xingchen Synthetic Materials Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Nantong Xingchen Synthetic Materials Drainage Endobronchial Blocker Product Offerings
7.7.5 Nantong Xingchen Synthetic Materials Recent Developments
7.8 Xinguang Chemical
7.8.1 Xinguang Chemical Company Information
7.8.2 Xinguang Chemical Introduction and Business Overview
7.8.3 Xinguang Chemical Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Xinguang Chemical Drainage Endobronchial Blocker Product Offerings
7.8.5 Xinguang Chemical Recent Developments
7.9 Wanhua Chemical
7.9.1 Wanhua Chemical Company Information
7.9.2 Wanhua Chemical Introduction and Business Overview
7.9.3 Wanhua Chemical Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Wanhua Chemical Drainage Endobronchial Blocker Product Offerings
7.9.5 Wanhua Chemical Recent Developments
7.10 Dongyue Group
7.10.1 Dongyue Group Company Information
7.10.2 Dongyue Group Introduction and Business Overview
7.10.3 Dongyue Group Drainage Endobronchial Blocker Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Dongyue Group Drainage Endobronchial Blocker Product Offerings
7.10.5 Dongyue Group Recent Developments
8 Industry Chain Analysis
8.1 Drainage Endobronchial Blocker Industrial Chain
8.2 Drainage Endobronchial Blocker Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Drainage Endobronchial Blocker Sales Model
8.5.2 Sales Channels
8.5.3 Drainage Endobronchial Blocker Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Drainage Endobronchial Blocker market is projected to grow from US$ 299 million in 2025 to US$ 372 million by 2032, at a CAGR of 3.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 143
USD 4900.00
(Single User License)
The global Drainage Endobronchial Blocker market size was US$ 299 million in 2025 and is forecast to reach a readjusted size of US$ 372 million by 2032 with a CAGR of 3.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 79
USD 4250.00
(Single User License)
The global Drainage Endobronchial Blocker market was valued at US$ 299 million in 2025 and is anticipated to reach US$ 372 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 111
USD 2900.00
(Single User License)
The global Drainage Endobronchial Blocker market size was US$ 290 million in 2024 and is forecast to a readjusted size of US$ 362 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
The global Drainage Endobronchial Blocker market is projected to grow from US$ 290 million in 2024 to US$ 362 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 133
USD 4900.00
(Single User License)
The global market for Drainage Endobronchial Blocker was estimated to be worth US$ 290 million in 2024 and is forecast to a readjusted size of US$ 362 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 101
USD 3950.00
(Single User License)
The global market for Drainage Endobronchial Blocker was valued at US$ 290 million in the year 2024 and is projected to reach a revised size of US$ 362 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published Date: 2025-03-10
Pages: 83
USD 2900.00
(Single User License)
The global market for Drainage Endobronchial Blocker was estimated to be worth US$ 281 million in 2023 and is forecast to a readjusted size of US$ 352 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030.
Published Date: 2024-12-06
Pages: 92
USD 3950.00
(Single User License)
The global Drainage Endobronchial Blocker revenue was US$ 281 million in 2023 and is forecast to a readjusted size of US$ 352 million by 2030 with a CAGR of 3.3% during the review period (2024-2030).
Published Date: 2024-12-06
Pages: 109
USD 4350.00
(Single User License)
Valued at US$ 290 million in 2024, the global Drainage Endobronchial Blocker market is forecast to reach US$ 352 million by 2030, at a CAGR of 3.3% during the forecast period.
Published Date: 2024-12-06
Pages: 142
USD 4900.00
(Single User License)
The global Drainage Endobronchial Blocker market is projected to grow from US$ 299 million in 2025 to US$ 372 million by 2032, at a CAGR of 3.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 143
The global Drainage Endobronchial Blocker market size was US$ 299 million in 2025 and is forecast to reach a readjusted size of US$ 372 million by 2032 with a CAGR of 3.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 79
The global Drainage Endobronchial Blocker market was valued at US$ 299 million in 2025 and is anticipated to reach US$ 372 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 111
The global Drainage Endobronchial Blocker market size was US$ 290 million in 2024 and is forecast to a readjusted size of US$ 362 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
The global Drainage Endobronchial Blocker market is projected to grow from US$ 290 million in 2024 to US$ 362 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 133
The global market for Drainage Endobronchial Blocker was estimated to be worth US$ 290 million in 2024 and is forecast to a readjusted size of US$ 362 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 101
The global market for Drainage Endobronchial Blocker was valued at US$ 290 million in the year 2024 and is projected to reach a revised size of US$ 362 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-03-10
Pages: 83
The global market for Drainage Endobronchial Blocker was estimated to be worth US$ 281 million in 2023 and is forecast to a readjusted size of US$ 352 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030.
Published: 2024-12-06
Pages: 92
The global Drainage Endobronchial Blocker revenue was US$ 281 million in 2023 and is forecast to a readjusted size of US$ 352 million by 2030 with a CAGR of 3.3% during the review period (2024-2030).
Published: 2024-12-06
Pages: 109
Valued at US$ 290 million in 2024, the global Drainage Endobronchial Blocker market is forecast to reach US$ 352 million by 2030, at a CAGR of 3.3% during the forecast period.
Published: 2024-12-06
Pages: 142
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now